sCD14 protein (Bridge BioResearch)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamesCD14 protein (Bridge BioResearch)
Drug Alias Namesoluble CD14 (Bridge BioResearch)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionMonocyte differentiation antigen CD14 stimulantsInsulin sensitizers
TargetsMonocyte differentiation antigen CD14
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A